We are live on ! Find out more
HAE icon

Haemonetics
HAE

181 hedge funds and large institutions have $2.22B invested in Haemonetics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 79 increasing their positions, 54 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $9K | Put options by funds: $3K

46% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 54

5% more capital invested

Capital invested by funds: $2.11B → $2.22B (+$108M)

3.54% more ownership

Funds ownership: 101.53% → 105.07% (+3.5%)

8% less funds holding

Funds holding: 197 → 181 (-16)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
181
Holders Change
-16
Holders Change %
-8.12%
% of All Funds
4.51%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
15
Increased
79
Reduced
54
Closed
24
Calls
$9K
Puts
$3K
Net Calls
+$6K
Net Calls Change
+$492K

Top Buyers

1
BlackRock
BlackRock
New York
+$245M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.2M
3
CWAM
Columbia Wanger Asset Management
Illinois
+$22.9M
4
HM
HealthCor Management
New York
+$17.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$13M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$75.4M
2
BIM
Bogle Investment Management
Massachusetts
-$5.89M
3
CCMH
Cornerstone Capital Management Holdings
New York
-$5.82M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.56M
5
HA
Heartland Advisors
Wisconsin
-$4.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
76
Citigroup
New York
$2.15M -$1.79M -45,752 -46%
D.E. Shaw & Co
77
D.E. Shaw & Co
New York
$2.11M -$184K -4,716 -8%
KeyBank National Association
78
KeyBank National Association
Ohio
$2.08M +$187K +4,795 +10%
PP
79
Prospector Partners
Connecticut
$2.04M – – –
State of Tennessee, Department of Treasury
80
State of Tennessee, Department of Treasury
Tennessee
$1.97M +$286K +7,318 +18%
American Century Companies
81
American Century Companies
Missouri
$1.86M +$15.8K +405 +0.9%
SFM
82
Systematic Financial Management
New Jersey
$1.79M -$10.3K -265 -0.6%
PI
83
PineBridge Investments
New York
$1.73M +$500K +12,806 +43%
Deutsche Bank
84
Deutsche Bank
Germany
$1.68M -$725K -18,555 -31%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.6M +$187K +4,792 +14%
State Board of Administration of Florida Retirement System
86
State Board of Administration of Florida Retirement System
Florida
$1.57M – – –
TPSF
87
Texas Permanent School Fund
Texas
$1.53M -$1.01K -26 -0.1%
Public Sector Pension Investment Board (PSP Investments)
88
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.49M – – –
NFA
89
Nationwide Fund Advisors
Ohio
$1.49M -$86.9K -2,225 -6%
MLICM
90
Metropolitan Life Insurance Company (MetLife)
New York
$1.42M – – –
Fidelity Investments
91
Fidelity Investments
Massachusetts
$1.4M -$5.56M -142,428 -81%
NSAM
92
North Star Asset Management
Wisconsin
$1.36M -$2.86M -73,195 -69%
AIG
93
American International Group
New York
$1.25M -$259K -6,641 -18%
TC
94
TFS Capital
Pennsylvania
$1.23M +$1.19M +30,385 New
SO
95
STRS Ohio
Ohio
$1.18M -$46.9K -1,200 -4%
Tudor Investment Corp
96
Tudor Investment Corp
Connecticut
$1.14M +$615K +15,737 +129%
UBS AM
97
UBS AM
Illinois
$1.11M +$269K +6,892 +34%
ASRS
98
Arizona State Retirement System
Arizona
$1.1M +$19.5K +500 +2%
IMOV
99
Investment Management of Virginia
Virginia
$1.03M -$7.69K -197 -0.8%
Envestnet Asset Management
100
Envestnet Asset Management
Illinois
$1.03M +$8.79K +225 +0.9%
2 3
4
5 6

HAE Hedge Fund Activity: Q1 2017 in Review

181 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2017, worth a combined $2.22B — up 5.1% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of HAE and 15 opened new positions — a net loss of 9 holders — while 54 trimmed existing stakes and 79 added.

The largest buyer was BlackRock, adding an estimated $245M. The largest seller was T. Rowe Price Associates, cutting an estimated $75.4M.

  • 181 institutional investors held Haemonetics (HAE) as of Q1 2017, down from 197 in Q4 2016.
  • Funds reported $2.22B of Haemonetics stock for Q1 2017, up 5.1% quarter-over-quarter.
  • 15 funds opened new Haemonetics positions in Q1 2017 and 24 closed out, a net change of -9 holders.
  • The largest Haemonetics buyer in Q1 2017 was BlackRock, an estimated $245M added.
  • The largest Haemonetics seller in Q1 2017 was T. Rowe Price Associates, an estimated $75.4M sold.

Based on aggregated 13F filings for Q1 2017.